Found 4 results

2009
AdRem Project Team and ADVANCE Management Committee, [Writing Committee], Beulens JWJ, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, McG Thom SA et al..  2009.  Effects of blood pressure lowering and intensive glucose control on incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia. 52:2027-36.[IF5.822].
2008
Stolk RP, van Schooneveld MJ, Cruickshank JK, Hughes AD, Stanton A, Lu J, Patel A, Thom SA, Grobbee DE, Vingerling JR et al..  2008.  Retinal vascular lesions in patients with type 2 diabetes mellitus of Caucasian and Asian origin . baseline results from the AdRem study . Diabetes Care. 31 :708-13.[IF7.851].
AdRem Project Team and Adv Management, Writing Committee, Beulens JW, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, Patel A, Thom SAM et al..  2008.  Effects of blood pressure lowering on incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial . Proceedings of the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) . <i>Diabetologia</i>. 2008;51(Suppl 1):S476-S476. [IF 5.822]
2007
Stolk RP, Vingerling JR, Kennedy Cruickshank J, Hughes AD, Stanton A, Juming L, Patel A, Thom SA, Grobbee DE, AdRem Project Team and ADVANCE Management Committee et al..  2007.  Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus. Contemp Clin Trials. 28:6-17.[ImpactFactor1.438].

Latest news

Recently added pages

Our focus

George Institute sites